Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Drug Discovery Informatics Market Growth Potential: How Will Market Size Change Through 2030?
The drug discovery informatics market size has seen rapid expansion in recent years. It is projected to grow from $4.06 billion in 2025 to $4.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.1%. The growth observed in the historic period is attributable to increasing pharmaceutical r&d complexity, expansion of clinical trial data volumes, adoption of computational chemistry tools, growth in bioinformatics applications, and rising demand for faster drug development cycles.
The drug discovery informatics market is anticipated to experience significant growth in the coming years. It is projected to expand to $7.74 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.7%. This expansion during the forecast period can be attributed to increasing investments in AI-enabled drug discovery, the rising adoption of precision medicine approaches, the broadening of collaborative research platforms, a growing focus on predictive modeling accuracy, and the increasing integration of informatics with laboratory systems. Major trends expected in this period include the escalating use of AI-driven drug discovery platforms, the rising adoption of cloud-based informatics solutions, the growing integration of big data analytics in R&D, an expansion of virtual screening and modeling tools, and an enhanced focus on data integration and management.
Download A Free Sample Report For Comprehensive Market Insights:
Drug Discovery Informatics Market Growth Drivers: What Factors Are Accelerating Expansion?
The increasing incidence of numerous chronic illnesses is anticipated to drive the expansion of the drug discovery informatics market in the future. Generally, chronic illnesses are defined as conditions lasting a year or more, requiring ongoing medical care, hindering daily activities, or both. Drug discovery informatics systems facilitate progress in managing chronic diseases by enabling researchers to investigate intricate and temporary molecular alterations underlying disease progression and drug responses, leading to the creation of multi-dimensional models representing the complete hierarchical system across healthy, diseased, and treated conditions. For example, in May 2024, the British Diabetic Association (Diabetes UK), a UK-based charity supporting patients, healthcare professionals, and research, reported that approximately 4.4 million individuals in the UK had a diabetes diagnosis as of 2022-23. Of these, around 8% were affected by type 1 diabetes, and roughly 90% by type 2 diabetes. Consequently, the growing incidence of diverse chronic diseases is fueling the expansion of the drug discovery informatics market.
Drug Discovery Informatics Market Categorization By Product Type And Application
The drug discovery informatics market covered in this report is segmented –
1) By Service: In-House, Outsourced
2) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis
3) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies
Subsegments:
1) By In-House: Data Management, Computational Chemistry, Bioinformatics, Cheminformatics, Predictive Modeling
2) By Outsourced: Contract Research Organizations (CROs), Specialized Informatics Providers, Data Analysis And Management Services
Drug Discovery Informatics Market Industry Trends: What Changes Are Reshaping Demand?
Key players within the drug discovery informatics market are emphasizing innovative solutions, such as AI-powered life sciences offerings, to boost their revenue. Artificial intelligence (AI)-driven life sciences solutions are significantly advancing both precision medicine and drug discovery, possessing the capacity to fully redefine the creation of new therapies and personalized treatment strategies. This enhancement improves the pace, accuracy, and overall efficiency of research and development procedures across the life sciences industry. For example, in May 2023, Google Cloud Platform, a US-based technology firm, introduced a suite of AI-powered life sciences solutions, comprising a target and lead identification suite and a multiomics suite. These innovations are intended to transform life sciences organizations by accelerating drug research and the introduction of novel treatments. Such methods can predict protein structures, ascertain the function of amino acids, and analyze genetic data through the application of high-performance computing, generative AI, and advanced computational instruments. The multiomics suite assists in developing tools for precision medicine, while the target and lead identification suite promotes more effective in silico drug design.
Drug Discovery Informatics Market Company Landscape And Strategic Competition
Major companies operating in the drug discovery informatics market are Accenture Plc.; Certara Inc.; Charles River Laboratories Inc.; Infosys Ltd.; Collaborative Drug Discovery Inc.; Eurofins DiscoverX Products Inc.; Jubilant Biosys Ltd.; Selvita S.A.; PerkinElmer Inc.; International Business Machines Corporation; Boehringer Ingelheim International GmbH; Oracle Corporation; Thermo Fisher Scientific Inc.; Albany Molecular Research Inc.; ChemAxon Ltd.; Amazon Web Services Inc.; Schrödinger LLC.; Core Informatics LLC; Informatics Matters Ltd.; Tata Consultancy Services Limited; Novo Informatics Pvt. Ltd.; IO Informatics Inc.; GVK Biosciences Private Limited; Dassault Systèmes SE; Recursion Pharmaceuticals Inc.; Cyclica Inc.; Valence Discovery Inc.; Valo Health Inc.; Cognizant Technology Solutions Corporation; Wipro Limited; Mindtree Limited; Persistent Systems Limited; Mphasis Limited
Access The Complete Drug Discovery Informatics Market Report:
Drug Discovery Informatics Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the drug discover informatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.